OptimizeRx (OPRX) Net Cash Flow (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Net Cash Flow data on file, last reported at -$3.2 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 200.09% year-over-year to -$3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (up 157.59% YoY), and the FY2025 full-year result was $10.0 million, up 2215.47% from the prior year.
• Net Cash Flow slipped to -$3.2 million in Q1 2026, from $3.8 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $4.3 million in Q1 2022 to a low of -$46.1 million in Q3 2022.
• A 5-year average of -$3.8 million and a median of $12000.0 in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow plunged 6068.58% in 2022 and surged 914.78% in 2024, its largest moves.
• Tracing OPRX's Net Cash Flow over 5 years: stood at -$23.1 million in 2022, then soared by 117.0% to $3.9 million in 2023, then sank by 169.87% to -$2.7 million in 2024, then soared by 240.06% to $3.8 million in 2025, then tumbled by 183.1% to -$3.2 million in 2026.
• Business Quant data shows OPRX's Net Cash Flow at -$3.2 million in Q1 2026, $3.8 million in Q4 2025, and $2.9 million in Q3 2025.